U.S. COVID-19 cases rise as XFG variant becomes dominant

As summer comes to a close, the United States is experiencing an increase in COVID-19 cases, driven by the XFG variant, which has established itself as the predominant nationwide strain. Cases continue to appear across different regions, emphasizing that the virus remains a persistent public health concern.

Current Cases and Regional Differences

Through the week ending August 16, 9.9% of the 32,998 Americans tested positive for COVID-19. This shows an increase of 1.4 percent compared with the previous week. During the same time, 0.4% of cases resulted in death, being steady from the previous week, while 1.2% of cases resulted in an emergency room visit, a slight increase of 0.2 percent.

Geographically, Western and Southern states including Washington, Oregon, Idaho, California, Nevada, Arizona, New Mexico, Texas, Oklahoma, Arkansas, Louisiana, and Alaska reported higher positivity rates. This uneven distribution shows the need for localized monitoring and public health responses.

Symptoms of Current COVID-19 Strains

While some people report having symptoms such as hoarseness or a sharp “razor blade” throat often with specific variants, health agencies like the CDC and WHO—highlight that no symptom is unique to any certain COVID-19 strain.

The CDC indicates that these symptoms as commonly linked with COVID-19:

• Fatigue
  
• Fever or chills
  
• Muscle or body aches
  
• Headache
  
• Cough
  
• Shortness of breath or difficulty in breathing
  
• Sore throat
  
• Congestion or runny nose
  
• Nausea or vomiting
  
• Loss of taste or smell
  

When to Seek Medical Care

CDC Recommends to Seek immediate medical care if you have any of the following:

• Trouble breathing
  
• Constant chest pain or pressure
  
• New confusion
  
• Inability to wake or stay awake
  
• Pale, gray, or blue skin, lips, or nail beds (depending on skin tone)
  

Vaccine Access Details

A dispute over COVID-19 vaccinations continues between federal regulators and public health organizations. On August 19, the American Academy of Pediatrics (AAP) issued its own vaccine guidance, diverging from recommendations by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

In May, Kennedy announced that COVID-19 vaccines would no longer be in the CDC’s routine immunization schedule for healthy children and pregnant persons. This decision departed from previous expert advice and bypassed the standard scientific review process. Under these revised guidelines, only individuals over 65 years old or those with preexisting medical conditions would be advised to get the COVID-19 vaccine. Experts have warned that this could restrict access for others who wish to be vaccinated.

State health officials and national professional groups, including the American Medical Association (AMA), AAP, and the American College of Obstetricians and Gynecologists (ACOG), have rejected Kennedy’s approach, continuing to support for vaccination of pregnant individuals and children.

As per the AAP immunization schedule, children aged six months to 23 months should receive the current COVID-19 vaccine to minimize the risk of severe disease. Children and adolescents between 2 and 18 years old who do not have high-risk conditions, such as immunosuppression, are eligible for vaccination and should be provided the shot if they have not previously immunized.

FAQs:

Q1. What is the current dominant COVID-19 variant?
The XFG variant is leading U.S. infections.

Q2. Are COVID-19 cases increasing?
Yes, case numbers are rising nationwide.